These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33468488)

  • 1. Adaptive Processes Change as Multiple Functions Evolve.
    Mira PM; Østman B; Guzman-Cole C; Sindi S; Barlow M
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
    Galán JC; Morosini MI; Baquero MR; Reig M; Baquero F
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2551-7. PubMed ID: 12878518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of non-β-lactams on stable variants of inhibitor-resistant TEM β-lactamase in uropathogenic Escherichia coli: implication for alternative therapy.
    Mukherjee SK; Mandal RS; Das S; Mukherjee M
    J Appl Microbiol; 2018 Mar; 124(3):667-681. PubMed ID: 29247576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
    Féria C; Ferreira E; Correia JD; Gonçalves J; Caniça M
    J Antimicrob Chemother; 2002 Jan; 49(1):77-85. PubMed ID: 11751770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten.
    Perilli M; Segatore B; Tavio M; Setacci D; Celenza G; De Santis F; Pellegrini C; Rossolini GM; Amicosante G
    J Chemother; 2007 Apr; 19(2):123-6. PubMed ID: 17434819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE.
    Tenover FC; Raney PM; Williams PP; Rasheed JK; Biddle JW; Oliver A; Fridkin SK; Jevitt L; McGowan JE;
    J Clin Microbiol; 2003 Jul; 41(7):3142-6. PubMed ID: 12843054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.
    Stapleton PD; Shannon KP; French GL
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1881-7. PubMed ID: 10428907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of bla
    Ingti B; Paul D; Maurya AP; Bora D; Chanda DD; Chakravarty A; Bhattacharjee A
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):13. PubMed ID: 28320396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitness trade-offs in blaTEM evolution.
    Mroczkowska JE; Barlow M
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2340-5. PubMed ID: 18443128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of TEM-type extended-spectrum β-lactamases in Escherichia coli by cephalosporins.
    Clasen J; Birkegård AC; Græsbøll K; Folkesson A
    J Glob Antimicrob Resist; 2019 Dec; 19():32-39. PubMed ID: 31048029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
    Ho WS; Balan G; Puthucheary S; Kong BH; Lim KT; Tan LK; Koh XP; Yeo CC; Thong KL
    Microb Drug Resist; 2012 Aug; 18(4):408-16. PubMed ID: 22394084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India.
    Taneja N; Mewara A; Kumar A; Verma G; Sharma M
    J Antimicrob Chemother; 2012 Jun; 67(6):1347-53. PubMed ID: 22410619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).
    Robin F; Delmas J; Chanal C; Sirot D; Sirot J; Bonnet R
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4443-7. PubMed ID: 16251281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in resistance to extended-spectrum cephalosporins in Salmonella isolated from retail chicken products in Japan.
    Noda T; Murakami K; Etoh Y; Okamoto F; Yatsuyanagi J; Sera N; Furuta M; Onozuka D; Oda T; Asai T; Fujimoto S
    PLoS One; 2015; 10(2):e0116927. PubMed ID: 25642944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain.
    Briñas L; Moreno MA; Teshager T; Zarazaga M; Sáenz Y; Porrero C; Dominguez L; Torres C
    Microb Drug Resist; 2003; 9(2):201-9. PubMed ID: 12820806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive Landscapes of Resistance Genes Change as Antibiotic Concentrations Change.
    Mira PM; Meza JC; Nandipati A; Barlow M
    Mol Biol Evol; 2015 Oct; 32(10):2707-15. PubMed ID: 26113371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins.
    Hammerum AM; Larsen J; Andersen VD; Lester CH; Skovgaard Skytte TS; Hansen F; Olsen SS; Mordhorst H; Skov RL; Aarestrup FM; Agersø Y
    J Antimicrob Chemother; 2014 Oct; 69(10):2650-7. PubMed ID: 24908045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.